Management of Diabetic Macular Edema in Current Clinical Practice: A ReviewPareja-Ríos A1*, López-Gálvez M2, Serrano-García MA1, Reyes-Rodríguez MA4, Cabrera-López F3 and Marrero-Saavedra MD4
- *Corresponding Author:
- Alicia Pareja Ríos
Hospital Universitario de Canarias
C/Ofra s/n. 38320, La Laguna
Tenerife, España, Spain
E-mail: [email protected]
Received date November 16, 2011; Accepted date February 15, 2012; Published date February 20, 2012
Citation: Pareja-Ríos A, López-Gálvez M, Serrano-García MA, Reyes-Rodríguez MA, Cabrera-López F, et al. (2012) Management of Diabetic Macular Edema in Current Clinical Practice: A Review. J Diabetes Metab S3:004. doi:10.4172/2155-6156.S3-004
Copyright: © 2012 Pareja-Ríos A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Diabetes is the most common cause of blindness in working age adults in developed countries. The last decade has seen major advances in the management of diabetic macular edema (DME), with the emergence of numerous therapeutic alternatives whose role is not yet fully defined. In this context, we present an updated review and guide to the clinical management of DME. In this review we discuss the role of complementary studies suggesting different courses of action based on the clinical, angiographic and tomographic classification of DME, and we highlight the role of laser therapy in the treatment of focal and multifocal macular edema. In cases of resistant or diffuse DME with central involvement, we propose the combined use of antiangiogenic drugs or intravitreal corticosteroids followed by laser. In patients with DME with a tractional component and functional repercussion, a surgical approach may be indicated.